Ajinomoto continues $100m investment to build out worldwide services
Aji Bio-Pharma will add a flexible fill line, packaging and labelling equipment to its worldwide manufacturing network, in an investment worth upwards of $100m.
Aji Bio-Pharma will add a flexible fill line, packaging and labelling equipment to its worldwide manufacturing network, in an investment worth upwards of $100m.
Pall Biotech signs an industry participation agreement with the New Jersey Innovation Institute to create two centres designed to develop and manufacture cell and gene therapies.
Biologics come with a hefty price tag, both to patients and manufacturers, but cost-effectiveness may be obtained through quality assurance.
Nanotechnology may be able to increase bioavailability in low-solubility drugs and improve a drug’s chance of success, according to Ascendia CEO.
Pall Corporation collaborates with ARTeSYN Biosolutions for single-use components and fluid management technologies.